Similar articles

• Prediction of HIV vaccine.

  Robson B, Fishleigh RV, Morrison CA. Robson B, et al. Nature. 1987 Jan 29-Feb 4;325(6103):395. doi: 10.1038/325395a0. Nature. 1987. PMID: 3468356 No abstract available.
• Modern vaccines. Human immunodeficiency virus and AIDS: challenges and progress.

  Schild GC, Minor PD. Schild GC, et al. Lancet. 1990 May 5;335(8697):1081-4. doi: 10.1016/0140-6736(90)92645-x. Lancet. 1990. PMID: 1970381 Review. No abstract available.
• Will antibody-dependent enhancement of HIV-1 infection be a problem with AIDS vaccines?

  Robinson WE Jr, Montefiori DC, Mitchell WM. Robinson WE Jr, et al. Lancet. 1988 Apr 9;1(8589):830-1. doi: 10.1016/s0140-6736(88)91695-9. Lancet. 1988. PMID: 2895350 No abstract available.
• The AIDS virus can take on many guises.

  Marx JL. Marx JL. Science. 1988 Aug 26;241(4869):1039-40. doi: 10.1126/science.2457946. Science. 1988. PMID: 2457946 No abstract available.
• Immunological consequences of HIV infection: advantage of being low responder casts doubts on vaccine development.

  Martínez-A C, Marcos MA, de la Hera A, Marquez C, Alonso JM, Toribio ML, Coutinho A. Martínez-A C, et al. Lancet. 1988 Feb 27;1(8583):454-7. doi: 10.1016/s0140-6736(88)91244-5. Lancet. 1988. PMID: 2449591 Review.